- Previous Close
122.20 - Open
121.00 - Bid 113.80 x --
- Ask --
- Day's Range
111.80 - 121.00 - 52 Week Range
103.60 - 141.00 - Volume
17,576 - Avg. Volume
13,173 - Market Cap (intraday)
2.267B - Beta (5Y Monthly) 1.19
- PE Ratio (TTM)
32.61 - EPS (TTM)
3.49 - Earnings Date Mar 25, 2025
- Forward Dividend & Yield 0.69 (0.61%)
- Ex-Dividend Date May 9, 2025
- 1y Target Est
146.60
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
www.medacta.comRecent News: MOVE.SW
View MorePerformance Overview: MOVE.SW
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MOVE.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MOVE.SW
View MoreValuation Measures
Market Cap
2.27B
Enterprise Value
2.47B
Trailing P/E
32.61
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.02
Price/Book (mrq)
6.24
Enterprise Value/Revenue
4.40
Enterprise Value/EBITDA
16.19
Financial Highlights
Profitability and Income Statement
Profit Margin
12.34%
Return on Assets (ttm)
7.81%
Return on Equity (ttm)
20.54%
Revenue (ttm)
590.58M
Net Income Avi to Common (ttm)
72.89M
Diluted EPS (ttm)
3.49
Balance Sheet and Cash Flow
Total Cash (mrq)
31.59M
Total Debt/Equity (mrq)
64.23%
Levered Free Cash Flow (ttm)
-15.85M